# Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT

Study · id `cardio:ct-nct07762755` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07762755](<https://clinicaltrials.gov/study/NCT07762755>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07762755

Browse, organ or system: Heart; Metabolism  
Browse, condition area: Risk and prevention; Coronary and vascular disease; Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT07762755. Randomized; single masking; primary purpose treatment. Start 2026-08-01 (anticipated); primary completion 2028-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT07762755, source copy `cardio:ctgov-nct07762755-2026-08-13`, retrieved 2026-10-26)
- Planned start: 2026-08-01 (anticipated) (ClinicalTrials.gov record NCT07762755, source copy `cardio:ctgov-nct07762755-2026-08-13`, retrieved 2026-10-26)
- Primary completion: 2028-12-31 (anticipated) (ClinicalTrials.gov record NCT07762755, source copy `cardio:ctgov-nct07762755-2026-08-13`, retrieved 2026-10-26)
- Completion: 2029-12-31 (anticipated) (ClinicalTrials.gov record NCT07762755, source copy `cardio:ctgov-nct07762755-2026-08-13`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07762755, source copy `cardio:ctgov-nct07762755-2026-08-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07762755-2026-08-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT
- Acronym: IPE-NaF
- Condition: Coronary Artery Disease
- Condition: Hyperlipidaemia
- Condition: Hypertriglyceridaemia
- Condition: Coronary Atherosclerosis
- Intervention (Drug): icosapent ethyl (IPE)
- Intervention (Drug): Standard LDL-C-Lowering Therapy
- Lead sponsor: China National Center for Cardiovascular Diseases
- Lead sponsor class: OTHER\_GOV
- Collaborator: Beijing Anzhen Hospital
- Collaborator class: OTHER
- Collaborator: Beijing Chao Yang Hospital
- Collaborator class: OTHER
- Collaborator: Beijing Municipal Health Commission
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: High triglycerides (`cardio:hypertriglyceridemia`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Icosapent ethyl (`cardio:icosapent-ethyl`)
- Registry lists this organization as the lead sponsor: China National Center for Cardiovascular Diseases (`cardio:org-china-national-center-for-cardiovascular-diseases`)
- Registry lists this organization as a collaborator: Beijing Anzhen Hospital (`cardio:org-beijing-anzhen-hospital`)
- Registry lists this organization as a collaborator: Beijing Chao Yang Hospital (`cardio:org-beijing-chao-yang-hospital`)
- Registry lists this organization as a collaborator: Beijing Municipal Health Commission (`cardio:org-beijing-municipal-health-commission`)

## Provenance

Content hash: bfaa247177e3489de8a9d1f7a00b877d11e60328c1046f8ee32e4537c3a6405d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
